In the replication phase, the MRVI1 locus (OR = 0.568, 95% CI: 0.4590.704, P_adj = 3.473 10 4 , P_HEIDI = 0.977) was identified, consistent with the results from the discovery cohort
SELENOW also appears to be a negative regulator for 14-3-3 proteins
Product Highlights 1mg per vial Long-acting IGF-1 analog Extended signaling research Growth & repair pathway studies Lyophilized for shelf stability For Research Use Only
Metabolic reprogramming helps to define different metastatic tropisms in colorectal cancer
L., Tran, L., Li, R., Wang, X., Newby, D
\Safety Profile: Mild, transient side effects